E Morel  Jr net worth and biography

E Jr Biography and Net Worth

Director of Stevanato Group

Dr. Morel served as Chief Executive Officer of West from 2002 through 2015 and Chairman from 2003 – 2015. During his tenure revenues tripled and market capitalization increased more than twelve times.  West was the top performing healthcare dividend stock on the NYSE over this time period. Prior to being named CEO he served as Chief Operating Officer and President of the Pharmaceutical Systems Division. His career at West started in 1992 as Director of R&D. From 1984 to 1992 he worked in various positions developing technology for space based remote imaging and the Strategic Defense Initiative. He served as an advisor to NASA on a number of Space Station programs and in 1989 was selected by the Astronaut Office for training as a Mission Specialist. His research has been funded by NASA, the Office of Naval Research, the National Science Foundation, and DARPA. Dr. Morel completed his undergraduate degree in Engineering at Lafayette College and his graduate studies at Cornell University in Materials Science and Veterinary Medicine and the Darden School of the University of Virginia. He received a D.Sc. (Hons) from Roanoke College. Dr. Morel serves as a Director of Stevanato Group SpA. He is Chairman Emeritus of the Board of Trustees of the Franklin Institute in Philadelphia, PA and also chairs the Foundation Board of the American Oncologic Hospital of the Fox Chase Cancer Center and the Travis Manion Foundatio. He is the founder of Progenitor Capital LLC and Chairs the Morel Family Foundation. He currently serves as a Trustee of the Darden school at the University of Virginia.

What is E Morel Jr's net worth?

The estimated net worth of E Morel Jr is at least €658.66 thousand as of June 15th, 2026. Jr owns 37,424 shares of Stevanato Group stock worth more than $658,662 as of June 26th. This net worth approximation does not reflect any other assets that Jr may own. Learn More about E Morel Jr's net worth.

How do I contact E Morel Jr?

The corporate mailing address for Jr and other Stevanato Group executives is PIOMBINO DESE (PD) VIA MOLINELLA 17, PADUA L6, 35017. Stevanato Group can also be reached via phone at 39049931811 and via email at [email protected]. Learn More on E Morel Jr's contact information.

Has E Morel Jr been buying or selling shares of Stevanato Group?

Over the course of the past ninety days, E Morel Jr has sold €25,515.37 of Stevanato Group stock. Most recently, Donald E. Morel, Jr. sold 1,493 shares of the business's stock in a transaction on Monday, June 15th. The shares were sold at an average price of €17.09, for a transaction totalling €25,515.37. Following the completion of the sale, the director now directly owns 37,424 shares of the company's stock, valued at €639,576.16. Learn More on E Morel Jr's trading history.

Are insiders buying or selling shares of Stevanato Group?

During the last year, insiders at the sold shares 4 times. They sold a total of 5,972 shares worth more than €102,061.48. The most recent insider tranaction occured on June, 15th when Director Madhavan Balachandran sold 1,493 shares worth more than €25,515.37. Insiders at Stevanato Group own 0.7% of the company. Learn More about insider trades at Stevanato Group.

Information on this page was last updated on 6/15/2026.

E Morel Jr Insider Trading History at Stevanato Group

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/15/2026Sell1,493€17.09€25,515.3737,424View SEC Filing Icon  
See Full Table

E Morel Jr Buying and Selling Activity at Stevanato Group

This chart shows Donald E Morel Jr's buying and selling at Stevanato Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Stevanato Group Company Overview

Stevanato Group logo
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
Read More

Today's Range

Now: €17.79
Low: €17.35
High: €18.67

50 Day Range

MA: €17.41
Low: €14.69
High: €19.03

2 Week Range

Now: €17.79
Low: €12.89
High: €28.00

Volume

327,959 shs

Average Volume

588,580 shs

Market Capitalization

€5.39 billion

P/E Ratio

30.15

Dividend Yield

N/A

Beta

0.78